Research & development > Clinical diagnostics

€85 million to fight Gram-negative pathogens

13 February, 2014

Over 30 European universities, research institutes and companies are joining forces in a six-year, €85 million program to develop novel antibiotics against Gram-negative pathogens.


What killed Knut, Berlin Zoo's polar bear?

07 February, 2014

After one of the most intensive investigations in veterinary history for a single animal, what caused the death of Berlin Zoological Garden's polar bear, Knut, has been revealed.


Developing single-dose vaccines for cattle

06 February, 2014

Researchers at The University of Queensland (UQ) are working on a single-dose (shelf-stable) vaccine that could be used to prevent common cattle diseases and reduce vaccination costs.


Identifying staph with a beacon, not a biopsy

04 February, 2014

Researchers at the University of Iowa (UI) have created a probe that can detect a common strain of staph bacteria (Staphylococcus aureus) in the body. Their method has been published in the journal Nature Medicine.


Positive phase 1 results for Admedus herpes trial

03 February, 2014

Healthcare company Admedus today announced interim study results on its phase 1 trial of a therapeutic vaccine for herpes simplex virus (HSV-2). The vaccine was found to be safe in the study subjects and was able to generate a T-cell response.


Modelling ovarian cancer

29 January, 2014

Scientists at Queensland University of Technology (QUT), funded by Cancer Council Queensland, are conducting research into the deadliest form of ovarian cancer.


Non-invasive, risk-free screen for Down syndrome

13 January, 2014

Researchers at Curtin University have assessed the use of a new non-invasive prenatal testing (NIPT) technique to identify Down syndrome in foetuses.


HPV testing at home

09 January, 2014

A Lund University study has found that HPV self-testing is as effective as tests done by doctors and, more importantly, more comfortable for women who find regular smear tests unpleasant.


Immunisation checks: there's an app for that

12 December, 2013

Cambridge Consultants and Diagnostics For All are working together to demonstrate a mobile phone application that can read a simple test for whether a child has been immunised.


South Australia's first autoimmune blood bank

07 November, 2013

Scientists from Flinders University and SA Pathology are setting up South Australia's first autoimmune blood bank, providing a central depository for research into different autoimmune diseases.


New nanoparticle delivers and monitors cancer drugs

01 November, 2013

Chemical engineers at the University of New South Wales (UNSW) have synthesised an iron oxide nanoparticle (IONP) that delivers cancer drugs to cells while simultaneously monitoring the drug release in real time.


University of Melbourne enters Parkinson's treatment deal

11 October, 2013

The University of Melbourne has entered into a drug development deal with Procypra Therapeutics, a US start-up company established by Collaborative Medicinal Development under the umbrella of venture capital firm Cthulhu Ventures.


Peanut butter can diagnose Alzheimer's disease

11 October, 2013

Health researchers at the University of Florida have found a quick and cheap way to test for early-stage Alzheimer's disease. The only equipment necessary is a container of peanut butter and a ruler.


Clinical Genomics acquisition brings bowel cancer blood test to the fore

09 October, 2013

Clinical Genomics - the developer of a blood-based biomarker test in collaboration with CSIRO Preventative Health Flagship and the Flinders Centre for Innovation in Cancer - has acquired US-based screening company Enterix from Quest Diagnostics, as well as its Sydney-based subsidiary.


Why some people don't get as sick and a universal flu vaccine

23 September, 2013

Investigating why some people seem to resist severe illness has led scientists closer to developing a universal flu vaccine.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd